Then, the activation of ROCK promoted the phosphorylation of myosin light chain (MLC) and myosin phosphatase targeting subunit 1 (MYPT1), which could aggravate endothelial dysfunction and inflammation (48, 49). The gene discussed is MLC1; the disease is endothelial dysfunction.